Company
CFM Pharma
- Biotech
- Founded:
- 2007
- Location:
- IJsselstein, Netherlands
Description
CFM Pharma is a Dutch clinical-stage biotech developing VANADIS®, a platform for tissue protection and repair in acute injury, with applications including cardiology, burns, and trauma.
CFM Pharma is located in the Netherlands ecosystem.
Related
FineHeartFineHeart develops FlowMaker as a therapy for advanced heart failure, creates clinical-stage cardiology technology, and leads an IPCEI…
BioportoBioporto provides clinicians with NGAL biomarker tools for acute kidney injury risk assessment and diagnosis, and supplies NGAL ELISA kits…
NTrans TechnologiesNTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for…
CUTISSCUTISS develops denovoSkin™, a personalized living skin tissue therapy for patients requiring skin surgery, and uses in-house GMP…
Osteo-PharmaOsteo-Pharma develops OsteoActivator technology that encapsulates low molecular weight bone-healing compounds in a biodegradable carrier to…
EDX MedicalEDX Medical develops diagnostic tests and point-of-care devices that combine molecular biology and digital technologies to provide…
SpliceBioSpliceBio builds protein splicing–based genetic medicines and develops therapeutics for diseases caused by mutations in large genes,…
MinervaXMinervaX is developing a prophylactic Group B Streptococcal (GBS) vaccine, AlpN GBS, that works as a clinical-stage immunization product…
IngenzaIngenza provides protein CRDMO services and custom biotech solutions for biologics, small molecules and sustainable biotech, offering…